In recent developments, the Indian Patent Office has granted a license to Natco Pharma to make and sell cancer drugs in India. The production and sale of this drug was previously a monopoly of German drugmaker Bayer. Natco's license to produce this drug means that medical treatment hitherto unaffordable for most patients will now be available at a fraction of the cost.
New hope for cancer treatment?
0 comments